232 related articles for article (PubMed ID: 37484197)
1. Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats.
Lamberty BG; Estrella LD; Mattingly JE; Emanuel K; Trease A; Totusek S; Sheldon L; George JW; Almikhlafi MA; Farmer T; Stauch KL
Brain Behav Immun Health; 2023 Aug; 31():100656. PubMed ID: 37484197
[TBL] [Abstract][Full Text] [Related]
2. Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease.
Stauch KL; Totusek S; Farmer T; Lamberty BG; Dyball KN; Almikhlafi MA; Fox HS
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33522500
[TBL] [Abstract][Full Text] [Related]
3. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
[TBL] [Abstract][Full Text] [Related]
4. Pink1/Parkin deficiency alters circulating lymphocyte populations and increases platelet-T cell aggregates in rats.
Manganaro JE; Emanuel K; Lamberty BG; George JW; Stauch KL
Res Sq; 2024 May; ():. PubMed ID: 38854001
[TBL] [Abstract][Full Text] [Related]
5. [Animal models for familial Parkinson's disease].
Takahashi R
Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
[TBL] [Abstract][Full Text] [Related]
6. Analysis of α-Synuclein Pathology in PINK1 Knockout Rat Brains.
Creed RB; Goldberg MS
Front Neurosci; 2018; 12():1034. PubMed ID: 30686993
[TBL] [Abstract][Full Text] [Related]
7. N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.
Eldeeb MA; Ragheb MA
Curr Genet; 2020 Aug; 66(4):693-701. PubMed ID: 32157382
[TBL] [Abstract][Full Text] [Related]
8. Formation of parkin aggregates and enhanced PINK1 accumulation during the pathogenesis of Parkinson's disease.
Um JW; Park HJ; Song J; Jeon I; Lee G; Lee PH; Chung KC
Biochem Biophys Res Commun; 2010 Mar; 393(4):824-8. PubMed ID: 20171192
[TBL] [Abstract][Full Text] [Related]
9. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
Clark IE; Dodson MW; Jiang C; Cao JH; Huh JR; Seol JH; Yoo SJ; Hay BA; Guo M
Nature; 2006 Jun; 441(7097):1162-6. PubMed ID: 16672981
[TBL] [Abstract][Full Text] [Related]
10. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
Hennis MR; Marvin MA; Taylor CM; Goldberg MS
Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
[TBL] [Abstract][Full Text] [Related]
11. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation.
Quinn PMJ; Moreira PI; Ambrósio AF; Alves CH
Acta Neuropathol Commun; 2020 Nov; 8(1):189. PubMed ID: 33168089
[TBL] [Abstract][Full Text] [Related]
12. PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates.
Matsui H; Gavinio R; Asano T; Uemura N; Ito H; Taniguchi Y; Kobayashi Y; Maki T; Shen J; Takeda S; Uemura K; Yamakado H; Takahashi R
Hum Mol Genet; 2013 Jun; 22(12):2423-34. PubMed ID: 23449626
[TBL] [Abstract][Full Text] [Related]
13. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
[TBL] [Abstract][Full Text] [Related]
14. AMP Kinase Activation is Selectively Disrupted in the Ventral Midbrain of Mice Deficient in Parkin or PINK1 Expression.
Hang L; Thundyil J; Goh GWY; Lim KL
Neuromolecular Med; 2019 Mar; 21(1):25-32. PubMed ID: 30411223
[TBL] [Abstract][Full Text] [Related]
15. PINK1-Parkin signaling in Parkinson's disease: Lessons from Drosophila.
Imai Y
Neurosci Res; 2020 Oct; 159():40-46. PubMed ID: 32035987
[TBL] [Abstract][Full Text] [Related]
16. Intestinal infection triggers Parkinson's disease-like symptoms in Pink1
Matheoud D; Cannon T; Voisin A; Penttinen AM; Ramet L; Fahmy AM; Ducrot C; Laplante A; Bourque MJ; Zhu L; Cayrol R; Le Campion A; McBride HM; Gruenheid S; Trudeau LE; Desjardins M
Nature; 2019 Jul; 571(7766):565-569. PubMed ID: 31316206
[TBL] [Abstract][Full Text] [Related]
17. Outlook of PINK1/Parkin signaling in molecular etiology of Parkinson's disease, with insights into
Wang Z; Chan SW; Zhao H; Miu KK; Chan WY
Zool Res; 2023 May; 44(3):559-576. PubMed ID: 37161651
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease-associated VPS35 mutant reduces mitochondrial membrane potential and impairs PINK1/Parkin-mediated mitophagy.
Ma KY; Fokkens MR; Reggiori F; Mari M; Verbeek DS
Transl Neurodegener; 2021 Jun; 10(1):19. PubMed ID: 34127073
[TBL] [Abstract][Full Text] [Related]
19. Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum.
Creed RB; Menalled L; Casey B; Dave KD; Janssens HB; Veinbergs I; van der Hart M; Rassoulpour A; Goldberg MS
Neuroscience; 2019 Jun; 409():169-179. PubMed ID: 31029729
[TBL] [Abstract][Full Text] [Related]
20. Pink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease.
Todd AM; Staveley BE
Genome; 2008 Dec; 51(12):1040-6. PubMed ID: 19088817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
